stockrow
Friday 6 November 2026
Export KOD’s income statement to Excel — free account
Kodiak Sciences Inc.
- EPS
- −1.94%
- Free cash flow
- −33.9%
Quarter to June 2026, against a year earlier
98.85
7.83
+8.60%
Follow KOD
Alert me
Kodiak Sciences Inc. (KOD) Return on assets
Kodiak Sciences Inc.'s return on assets over the twelve months to 30 June 2026 was −94.3%, down 27.3 percentage points from fiscal 2025 (−66.9%). Over the past ten years it has ranged from −363.8% (fiscal 2017) to −18.7% (fiscal 2020); the current reading is higher than 40% of that period. That is below the Biotechnology industry median of −45.6% and below the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −66.9% | (23.70) |
| FY2024 | −43.2% | 2.22 |
| FY2023 | −45.5% | (2.96) |
| FY2022 | −42.5% | (15.42) |
| FY2021 | −27.1% | (8.42) |
| FY2020 | −18.7% | 2.34 |
| FY2019 | −21.0% | 65.85 |
| FY2018 | −86.9% | 276.95 |
| FY2017 | −363.8% | (137.10) |
| FY2016 | −226.7% | — |
Against its own ten years
Low −363.8%
High −18.7%
Ten-year median
−44.4%
Current reading's percentile
40
Return on assets against peers
| Company | Return on assets |
|---|---|
| LGND Ligand Pharmaceuticals Incorporated compare | 2.77% |
| PTCT PTC Therapeutics, Inc. compare | −3.62% |
| ORKA Oruka Therapeutics, Inc. compare | −17.8% |
| IONS Ionis Pharmaceuticals, Inc. compare | −18.9% |
| BLTE Belite Bio, Inc. Sponsored ADR compare | −21.6% |
| CGON CG Oncology, Inc. compare | −25.1% |
| IMVT Immunovant, Inc. compare | −71.1% |
| KOD Kodiak Sciences Inc. | −94.3% |
| MIRM Mirum Pharmaceuticals, Inc. compare | −99.8% |
| Biotechnology industry median | −45.6% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)